Alkaloids Exhibit a Meaningful Function as Anticancer Agents by Restraining Cellular Signaling Pathways

Wen Xu1, Bei Wang1, Yisong Gao1

  • 1College of Medical Science, China Three Gorges University, Yichang 443002, China.

Insights

Alkaloids, natural compounds, show promise in cancer treatment by inhibiting key tumor signaling pathways like NF-kB, PI3K/AKT, MAPK, and P53. This review explores their potential as targeted cancer prevention drugs.

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Alkaloids are vital natural compounds with significant clinical applications.
  • Cellular signaling pathways regulate crucial tumor cell functions, including proliferation and apoptosis.
  • Dysregulated signaling pathways are hallmarks of cancer, making them therapeutic targets.

Purpose of the Study:

  • To review the antitumor effects of alkaloids by targeting classical cellular signaling pathways.
  • To elucidate the molecular mechanisms through which alkaloids modulate these pathways.
  • To assess the potential of alkaloids as targeted cancer prevention agents.

Main Methods:

  • Systematic literature retrieval from PubMed.
  • Focus on four major signaling pathways: NF-kB, PI3K/AKT, MAPK, and P53.
  • Analysis of molecular mechanisms underlying alkaloid-mediated pathway inhibition.

Main Results:

  • Alkaloids demonstrate antitumor activity through the inhibition of key signaling pathways.
  • Specific molecular mechanisms of action for various alkaloids are detailed.
  • Evidence supports the role of alkaloids in modulating tumor progression.

Conclusions:

  • Alkaloids represent a promising class of compounds for cancer therapy.
  • Targeting specific signaling pathways with alkaloids offers a strategy for cancer prevention.
  • Further research is warranted to fully realize the therapeutic potential of alkaloids in oncology.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K